Primecap Management’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.74M | Sell |
|
|||||
|
2025
Q1 | $3.64M | Sell |
|
|||||
|
2024
Q4 | $5.15M | Sell |
|
|||||
|
2024
Q3 | $7.69M | Sell |
|
|||||
|
2024
Q2 | $7.47M | Sell |
|
|||||
|
2024
Q1 | $6.51M | Sell |
|
|||||
|
2023
Q4 | $3.96M | Sell |
|
|||||
|
2023
Q3 | $4.29M | Sell |
|
|||||
|
2023
Q2 | $4.69M | Sell |
|
|||||
|
2023
Q1 | $8.07M | Sell |
|
|||||
|
2022
Q4 | $35.4M | Sell |
|
|||||
|
2022
Q3 | $52.6M | Sell |
|
|||||
|
2022
Q2 | $62.9M | Sell |
|
|||||
|
2022
Q1 | $92M | Sell |
|
|||||
|
2021
Q4 | $235M | Sell |
|
|||||
|
2021
Q3 | $323M | Sell |
|
|||||
|
2021
Q2 | $310M | Sell |
|
|||||
|
2021
Q1 | $363M | Sell |
|
|||||
|
2020
Q4 | $313M | Sell |
|
|||||
|
2020
Q3 | $313M | Sell |
|
|||||
|
2020
Q2 | $449M | Sell |
|
|||||
|
2020
Q1 | $366M | Buy |
|
|||||
|
2019
Q4 | $433M | Buy |
|
|||||
|
2019
Q3 | $348M | Buy |
|
|||||
|
2019
Q2 | $679M | Sell |
|
|||||
|
2019
Q1 | $650M | Sell |
|
|||||
|
2018
Q4 | $638M | Sell |
|
|||||
|
2018
Q3 | $1.23B | Sell |
|
|||||
|
2018
Q2 | $1.02B | Sell |
|
|||||
|
2018
Q1 | $2.24B | Sell |
|
|||||
|
2017
Q4 | $1.34B | Sell |
|
|||||
|
2017
Q3 | $555M | Buy |
|
|||||
|
2017
Q2 | $452M | Buy |
|
|||||
|
2017
Q1 | $504M | Buy |
|
|||||
|
2016
Q4 | $263M | Buy |
|
|||||
|
2016
Q3 | $344M | Buy |
|
|||||
|
2016
Q2 | $285M | Sell |
|
|||||
|
2016
Q1 | $275M | Buy |
|
|||||
|
2015
Q4 | $333M | Buy |
|
|||||
|
2015
Q3 | $216M | Buy |
|
|||||
|
2015
Q2 | $247M | Buy |
|
|||||
|
2015
Q1 | $215M | Buy |
|
|||||
|
2014
Q4 | $283M | Buy |
|
|||||
|
2014
Q3 | $219M | Buy |
|
|||||
|
2014
Q2 | $203M | Buy |
|
|||||
|
2014
Q1 | $188M | Buy |
|
|||||
|
2013
Q4 | $142M | Buy |
|
|||||
|
2013
Q3 | $104M | Buy |
|
|||||
|
2013
Q2 | $87.5M | Buy |
|